RecruitingNCT05935189
Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens
Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens for Genetic and Histologic Research
Sponsor
Nikomed Medical Center
Enrollment
500 participants
Start Date
Jul 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of the study is to establish a cancer registry to facilitate research and assist in the identification of additional risk factors for hepatocellular carcinoma. The main objectives are: 1. provide a mechanism to store the information about subjects with hepatocellular carcinoma 2. use of tissue samples for translational/further research purposes
Eligibility
Inclusion Criteria3
- Patients with biopsy-confirmed diagnosis of HCC
- Armenian descent
- Having given their signed Informed consent
Exclusion Criteria1
- Failure to obtain informed consent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05935189
Related Trials
Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients
NCT056298451 location
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors
NCT060775911 location
Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab
NCT0679611410 locations
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
NCT054683592 locations
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
NCT0552895214 locations